Royal Bank of Canada
KMTS

Royal Bank of Canada’s Kestra Medical Technologies KMTS Stock Holding History

Royal Bank of Canada’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Sell
13,885
-1,269
-8% -$29.9K ﹤0.01% 4512
2025
Q4 		$402K Buy
15,154
+13,202
+676% +$340K ﹤0.01% 4331
2025
Q3 		$46K Buy
1,952
+80
+4% +$1.43K ﹤0.01% 5863
2025
Q2 		$31K Buy
+1,872
New +$40.9K ﹤0.01% 6121

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Royal Bank of Canada's KMTS Position: Q1 2026 in Review

Royal Bank of Canada reduced its Kestra Medical Technologies (KMTS) stake by 8.4% in Q1 2026, selling an estimated $29.9K and leaving 13,885 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #4512.

Royal Bank of Canada first reported a position in KMTS in Q2 2025 and has held it in 4 quarters since. The position peaked at $402K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Royal Bank of Canada held 13,885 shares of Kestra Medical Technologies worth $277K as of Q1 2026.
  • Royal Bank of Canada sold 1,269 Kestra Medical Technologies shares in Q1 2026, an estimated $29.9K.
  • Kestra Medical Technologies made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4512 holding.
  • Royal Bank of Canada first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 4 quarters since.
  • Royal Bank of Canada's Kestra Medical Technologies position peaked at $402K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.